SAM
MIRM icon

Silvercrest Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Silvercrest Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.05M Sell
77,278
-3,713
-5% -$373K 0.06% 369
2026
Q1 		$7.48M Sell
80,991
-9,065
-10% -$853K 0.05% 361
2025
Q4 		$7.11M Hold
90,056
– – 0.05% 383
2025
Q3 		$6.6M Sell
90,056
-45,859
-34% -$2.92M 0.04% 387
2025
Q2 		$6.92M Hold
135,915
– – 0.05% 378
2025
Q1 		$6.12M Sell
135,915
-785
-0.6% -$37K 0.04% 380
2024
Q4 		$5.65M Sell
136,700
-1,347
-1% -$56.1K 0.04% 400
2024
Q3 		$5.38M Sell
138,047
-82,443
-37% -$3.29M 0.04% 374
2024
Q2 		$7.54M Buy
220,490
+57,673
+35% +$1.51M 0.05% 318
2024
Q1 		$4.09M Buy
162,817
+63,871
+65% +$1.76M 0.03% 423
2023
Q4 		$2.92M Sell
98,946
-53,464
-35% -$1.62M 0.02% 453
2023
Q3 		$4.82M Sell
152,410
-81,858
-35% -$2.24M 0.04% 366
2023
Q2 		$6.06M Buy
234,268
+32,888
+16% +$875K 0.04% 337
2023
Q1 		$4.84M Hold
201,380
– – 0.04% 354
2022
Q4 		$3.93M Buy
201,380
+41,343
+26% +$817K 0.03% 378
2022
Q3 		$3.36M Sell
160,037
-4,350
-3% -$105K 0.03% 386
2022
Q2 		$3.2M Sell
164,387
-7,528
-4% -$178K 0.02% 403
2022
Q1 		$3.79M Sell
171,915
-114,325
-40% -$2.33M 0.02% 412
2021
Q4 		$4.57M Buy
+286,240
New +$4.45M 0.03% 392

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Silvercrest Asset Management's MIRM Position: Q2 2026 in Review

Silvercrest Asset Management reduced its Mirum Pharmaceuticals (MIRM) stake by 4.6% in Q2 2026, selling an estimated $373K and leaving 77,278 shares worth $9.05M. The position accounts for 0.06% of the portfolio, ranked #369.

Silvercrest Asset Management first reported a position in MIRM in Q4 2021 and has held it in 19 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Silvercrest Asset Management held 77,278 shares of Mirum Pharmaceuticals worth $9.05M as of Q2 2026.
  • Silvercrest Asset Management sold 3,713 Mirum Pharmaceuticals shares in Q2 2026, an estimated $373K.
  • Mirum Pharmaceuticals made up 0.06% of Silvercrest Asset Management's portfolio in Q2 2026, its #369 holding.
  • Silvercrest Asset Management first reported a position in Mirum Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Silvercrest Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.